215 related articles for article (PubMed ID: 38238581)
41. [Not Available].
Liu L; Chen Y; Zhang T; Cui G; Wang W; Zhang G; Li J; Zhang Y; Wang Y; Zou Y; Ren Z; Xue W; Sun R
Adv Sci (Weinh); 2024 May; 11(20):e2302379. PubMed ID: 38566431
[TBL] [Abstract][Full Text] [Related]
42. An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.
Yun D; Yang Z; Zhang S; Yang H; Liu D; Grützmann R; Pilarsky C; Britzen-Laurent N
Front Cell Dev Biol; 2022; 10():975684. PubMed ID: 36060802
[TBL] [Abstract][Full Text] [Related]
43. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
44. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
45. Overview of distinct 5-methylcytosine profiles of messenger RNA in normal and knock-down NSUN2 colorectal cancer cells.
Lin Y; Zhao Z; Nie W; Huang M; Cai J; Wang Y; Wang H; Huang Y; Bai Y
Front Genet; 2023; 14():1121063. PubMed ID: 37168511
[No Abstract] [Full Text] [Related]
46. Systematic Analysis of Tumor Microenvironment Patterns and Oxidative Stress Characteristics of Endometrial Carcinoma Mediated by 5-Methylcytosine Regulators.
Dong C; Dang L; Gao X; Xu R; Zhang H; Zhang X
Oxid Med Cell Longev; 2022; 2022():6431164. PubMed ID: 36187339
[TBL] [Abstract][Full Text] [Related]
47. Novel insights into the role of 5-Methylcytosine RNA methylation in human abdominal aortic aneurysm.
He Y; Zhang H; Yin F; Guo P; Wang S; Wu Y; Xin S; Han Y; Zhang J
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1147-1165. PubMed ID: 34856760
[No Abstract] [Full Text] [Related]
48. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
Pan J; Huang Z; Xu Y
Front Oncol; 2021; 11():657466. PubMed ID: 34195072
[TBL] [Abstract][Full Text] [Related]
49. Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
Pan Q; Yi C; Zhang Y
Front Oncol; 2022; 12():884377. PubMed ID: 35686101
[TBL] [Abstract][Full Text] [Related]
50. Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma.
Liu Y; Zheng S; Wang T; Fang Z; Kong J; Liu J
Front Cell Dev Biol; 2022; 10():842220. PubMed ID: 35252205
[No Abstract] [Full Text] [Related]
51. RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer.
Yang S; Luo Y; Zhou D; Xiang J; Xi X
Transl Cancer Res; 2023 Oct; 12(10):2556-2571. PubMed ID: 37969377
[TBL] [Abstract][Full Text] [Related]
52. Transcriptome-Wide 5-Methylcytosine Functional Profiling of Long Non-Coding RNA in Hepatocellular Carcinoma.
He Y; Shi Q; Zhang Y; Yuan X; Yu Z
Cancer Manag Res; 2020; 12():6877-6885. PubMed ID: 32801911
[TBL] [Abstract][Full Text] [Related]
53. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
Xiao Y; Li J; Wu J
BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
[TBL] [Abstract][Full Text] [Related]
55. Development of the expression and prognostic significance of m
Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
[TBL] [Abstract][Full Text] [Related]
56. YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro study.
Li Z; Lu W; Yin F; Huang A
Transl Oncol; 2024 Jul; 45():101965. PubMed ID: 38688048
[TBL] [Abstract][Full Text] [Related]
57. The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment.
Zhou H; Meng M; Wang Z; Zhang H; Yang L; Li C; Zhang L
Front Oncol; 2022; 12():814742. PubMed ID: 35372082
[TBL] [Abstract][Full Text] [Related]
58. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
59. Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer.
Song L; Wang S; Li Q; Lu Y; Yang R; Feng X
J Oncol; 2023; 2023():9931419. PubMed ID: 36936373
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma.
Lu Q; Liu L; Wang S; Zhang Q; Li L
Front Genet; 2022; 13():990594. PubMed ID: 36339006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
